These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9932201)

  • 1. The role of oral 1C antiarrhythmic drugs in terminating atrial fibrillation.
    Capucci A; Villani GQ; Piepoli MF; Aschieri D
    Curr Opin Cardiol; 1999 Jan; 14(1):4-8. PubMed ID: 9932201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.
    Alboni P; Botto GL; Baldi N; Luzi M; Russo V; Gianfranchi L; Marchi P; Calzolari M; Solano A; Baroffio R; Gaggioli G
    N Engl J Med; 2004 Dec; 351(23):2384-91. PubMed ID: 15575054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment.
    Alboni P; Botto GL; Boriani G; Russo G; Pacchioni F; Iori M; Pasanisi G; Mancini M; Mariconti B; Capucci A
    Heart; 2010 Apr; 96(7):546-9. PubMed ID: 20350992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.
    Deneer VH; Borgh MB; Kingma JH; Lie-A-Huen L; Brouwers JR
    Pharm World Sci; 2004 Apr; 26(2):66-78. PubMed ID: 15085940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Instead of long-term antiarrhythmia drug treatment--stand-by therapy for atrial fibrillation].
    Stiefelhagen P
    MMW Fortschr Med; 2010 Feb; 152(7):18. PubMed ID: 20364502
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of patients with acute atrial fibrillation in the ED.
    Conti A; Del Taglia B; Mariannini Y; Pepe G; Vanni S; Grifoni S; Abbate R; Michelucci A; Padeletti L; Gensini GF
    Am J Emerg Med; 2010 Oct; 28(8):903-10. PubMed ID: 20825922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
    Alboni P; Botto GL; Baldi N
    Ital Heart J Suppl; 2005 Jun; 6(6):335-40. PubMed ID: 16013424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation.
    Schumacher B; Jung W; Lewalter T; Vahlhaus C; Wolpert C; Lüderitz B
    Am J Cardiol; 1999 Mar; 83(5):710-3. PubMed ID: 10080423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of flecainide.
    Tamargo J; Capucci A; Mabo P
    Drug Saf; 2012 Apr; 35(4):273-89. PubMed ID: 22435343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can recent-onset atrial fibrillation be safely and successfully treated with self-administered antiarrhythmic drugs?
    Wyse DG
    Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):132-3. PubMed ID: 16265454
    [No Abstract]   [Full Text] [Related]  

  • 13. The "pill-in-the-pocket" approach to atrial fibrillation.
    Konety SH; Olshansky B
    N Engl J Med; 2005 Mar; 352(11):1150-1; author reply 1150-1. PubMed ID: 15789457
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion of recent onset atrial fibrillation: which drug is faster?
    Conde D
    Am J Emerg Med; 2013 Sep; 31(9):1410-1. PubMed ID: 23796978
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation.
    Nabar A; Rodriguez LM; Timmermans C; Smeets JL; Wellens HJ
    Am J Cardiol; 1999 Mar; 83(5):785-7, A10. PubMed ID: 10080440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation.
    Marcus FI
    Am J Cardiol; 1990 Aug; 66(3):366-7. PubMed ID: 2114783
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for the use of propafenone in treating supraventricular arrhythmias.
    Kishore AG; Camm AJ
    Drugs; 1995 Aug; 50(2):250-62. PubMed ID: 8521758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs.
    Balla I; Petrela E; Kondili A
    Anadolu Kardiyol Derg; 2011 Nov; 11(7):600-6. PubMed ID: 21911317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral propafenone for rapid conversion of recent onset atrial fibrillation--a review.
    Hughes C; Sunderji R; Gin K
    Can J Cardiol; 1997 Sep; 13(9):839-42. PubMed ID: 9343033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
    Podrid PJ; Anderson JL
    Am J Cardiol; 1996 Aug; 78(4):430-4. PubMed ID: 8752188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.